Active Pharmaceutical Ingredients and High Potency API Industry Data Book Covers Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Markets.
The global active pharmaceutical ingredients market was valued at USD 209.71 billion in 2021 and is anticipated to witness growth at a rate of 5.9% over the forecast period. The global high potency API market was valued at USD 23.60 billion in 2021 and is anticipated to witness growth at a rate of 6.2% over the forecast period. Access the Global Active Pharmaceutical Ingredients and High Potency API Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies. Active Pharmaceutical Ingredients Market Growth & Trends The global active pharmaceutical ingredients market size is expected to reach USD 352.98 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population. The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process. The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field. The active pharmaceutical Ingredients market was positively influenced by the COVID-19 pandemic, as countries and significant players produce large quantities of components to meet the demand for the treatment of COVID-19. As a result of the outbreak, drug companies have changed the companies’ strategies to focus on a larger patient population. To treat coronavirus, the U.S., for example, requested that HCQ be imported from India. The virus has also impacted Canada's medicine supply system, potentially causing complications for patients. The increasing importance of generics, rise in consumption of biopharmaceuticals, and expanding drug research and development activities for drug manufacturing are the primary drivers driving the growth of the market. However, the market's expansion is likely to be hampered by unfavourable drug price control regimes in several countries and high manufacturing costs. Order your copy of Free Sample of “Active Pharmaceutical Ingredients and High Potency API Industry Data Book - Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research High Potency Active Pharmaceutical Ingredients Market Growth & Trends The global high potency active pharmaceutical ingredients market size is expected to reach USD 40.66 billion by 2030 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the HPAPI market is attributed to rising incidence of cancer, growing targeted therapies, and increasing application of high potency active pharmaceutical ingredients (HPAPI) in treating target diseases. Rising prevalence of cancer is expected to be a major factor. According to the WHO, cancer is the second leading cause of death, accounting for around 9.9 million deaths in 2020. Due to the growing number of people who contract the disease, cancer is regarded as one of the major health risks. The CDC states that factors such as smoking, obesity, alcohol use, and UV radiation exposure are risk factors for cancer since they contribute to the overall burden of the illness. With limited treatment options and side effects associated with chemotherapy, there is a rising popularity of targeted therapy as it does not damage non-cancerous cells. In May 2021, Amgen, Inc. received the U.S. FDA approval for the launch of LUMAKRAS for treating patients with KRAS G12C-mutated locally advanced or metastatic NSCLC. LUMAKRAS is the first targeted product for the treatment of G12C-mutated KRAS NSCLC patients. This is likely to increase the demand for HPAPIs in the coming years. Characteristics of these anti-cancerous drugs, such as minimum exposure of drugs to non-cancerous cell and their effectiveness, are contributing to market growth. The proprietary technology of companies, such as drug designing & delivery technology helps develop novel treatment and HPAPI alternatives through collaborations with other key players, which may increase the number of research initiatives. For instance, in November 2021, the company launched a novel technology ChetoSensar to enhance the development of Antibody–Drug Conjugates (ADCs) therapies. This initiative is aimed at significantly doubling the company’s efforts to boost its production of HPAPIs and ADCs. Go through the table of content of Active Pharmaceutical Ingredients and High Potency API Industry Data Book to get a better understanding of the Coverage & Scope of the study. Competitive Landscape Key players operating in the Active Pharmaceutical Ingredients and High Potency API Industry are – • Novo Nordisk • Merck KGaA • Novartis AG • Aurobindo Pharma • Piramal Pharma • Teva Pharmaceutical Industries Ltd. • AbbVie, Inc. • BASF SE • Boehringer Ingelheim International GmbH • CordenPharma • Merck & Co., Inc. • Dr. Reddy’s Laboratories Ltd. • Cipla, Inc. • Bristol-Myers Squibb Company • Sun Pharmaceutical Industries Ltd. • Sanofi • Pfizer, Inc. • Viatris Inc. • Albemarle Corporation • Aurobindo Pharma Grand View Research’s Active Pharmaceutical Ingredients and High Potency API industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Check out more Industry Data Books, published by Grand View Research About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com/sector-reports-list Follow Us: LinkedIn | Twitter
0 Comments
Veterinary Imaging Instrument Industry Data Book Covers Veterinary X-Ray, Veterinary Ultrasound, Animal MRI and Animal/Veterinary CT Imaging Markets. The global market size for the veterinary imaging instrument was estimated at USD 1.44 Billion in 2021 and is anticipated to increase at a CAGR of 5.7% from 2022 to 2030. Access the Global Veterinary Imaging Instrument Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies. Veterinary X-ray Market Growth & Trends The global veterinary X-ray market size is expected to reach USD 1.06 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 6.31% from 2023 to 2030. The key factors driving the market growth include a rise in the prevalence of orthopedic diseases in animals, a growing pet population, increased animal health spending, high pet insurance, and a rise in the number of veterinary practitioners. Similarly, the rising prevalence of chronic disease in pets due to obesity is contributing to market growth. Pet obesity has become an epidemic in the U.S. as per The Association for Pet Obesity Prevention (APOP) 59% of dogs and 61% of cats classified as overweight or having obesity in 2022. Obesity causes chronic conditions such as osteoarthritis that frequently require diagnosis and surgical intervention. According to Banfield Pet Hospital, the most common osteoarthritis conditions affecting dogs and cats in 2017 were arthritis/DJD, tendon or ligament conditions, and hip and pelvis conditions. This results in increased use of X-rays for disease diagnosis. The COVID-19 pandemic caused significant growth in the pet industry by establishing new trends such as increased pet ownership and animal spending. The COVID-19 pandemic has impacted negatively on a variety of industries worldwide. The pandemic had a significant impact on the healthcare industry. The unexpected outbreak of the COVID-19 pandemic induced the implementation of strict lockdown restrictions in several countries, resulting in the shutdown of numerous vet facilities and a negative impact on global demand for veterinary x-ray imaging. Order your copy of Free Sample of “Veterinary Imaging Instrument Industry Data Book - Veterinary X-Ray, Veterinary Ultrasound, Animal MRI and Animal/Veterinary CT Imaging Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Veterinary CT Imaging Market Growth & Trends The global veterinary CT imaging market size is expected to reach USD 640.9 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.03% from 2023 to 2030. The key factors driving the market growth include the growing adoption of pets, an increasing number of veterinary clinics in developing countries with improved infrastructure, advancing veterinary imaging technologies, and emerging diagnostic centers for veterinary practices. One of the major drivers propelling the market growth for veterinary CT imaging is increasing access to computed tomography among general veterinary practitioners. The ability to produce 3D reconstructions is crucial for this wide acceptance of CT in veterinary medicine since it helps surgeons and other medical professionals to detect the target site before the treatment and serves as a useful teaching tool for complex anatomy and physiology. Although there is still much research to be done regarding the use of CT scanners in veterinary medicine, recent clinic advancements have focused on using technology coupled with movement-restricting devices to create CT scan images without having to put a patient to sleep, thereby lowering the morbidity rates related to general anaesthesia. Diagnostic imaging modalities play a vital role in veterinary diagnosis and treatment. The recent advancements in the veterinary industry and imaging technologies over the past decade have aided veterinarians in precisely diagnosing several complicated diseases with ease. The high-resolution anatomical images developed by CT equipment help evaluate the pet’s internal anatomy with more accuracy than standard radiography. Recently, CT scans are widely performed in combination with a contrast reagent that must be given intravenously before imaging. This allows veterinarians to visualize the sites with increased blood flow or clots accurately. Veterinary MRI Market Growth & Trends The global veterinary MRI market size is expected to reach USD 360 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 7.38% from 2023 to 2030. The key factors driving the growth include the rising pet expenditures, rate of advanced diagnostics procedures, strategic initiatives by companies, and increasing adoption by end-users.In October 2020, Davies Veterinary Specialists in the U.K. and part of Mars Veterinary Health invested about 1.5 million pounds in acquiring new magnetic resonance imaging (MRI) and CT systems. This supported its growth objectives of establishing new veterinary teams and increasing the hospital footprint. The COVID-19 pandemic impacted the market notably with both challenges and opportunities. Market stakeholders witnessed limited access to veterinary care during the first half of 2020, while manufacturers faced operational and supply chain hurdles. However, the pandemic raised awareness about animal health in general as pet parents stayed at home and were thus more attuned to changes in their pet’s behavior. This factor combined with the growing humanization of pets is expected to fuel the market’s growth in the coming years. The expansion of service offerings to include MRI training and education is another key factor contributing to the market growth.MRI scanners should be operated by trained technologists as many factors have to be considered when preparing an animal for an MRI. Most times, this training is not part of the veterinary curriculum and must be acquired as part of the training program in a radiologic technology school or by attending special training sessions. MRI VET Academy by Esaote SPA offers free online learning courses that introduce general practitioners to the neurological patient, and common spinal and brain diseases. Go through the table of content of Veterinary Imaging Instrument Industry Data Book to get a better understanding of the Coverage & Scope of the study. Competitive Landscape Key players operating in the Veterinary Imaging Instrument Industry are – • IDEXX Laboratories, Inc. • Canon Medical Systems Corporation • FUJIFILM Holdings America Corporation • Samsung • Heska Corporation • Butterfly Network, Inc. • Carestream Health • Midmark Corporation • ESAOTE SPA • SOUND Grand View Research’s Veterinary Imaging Instrument industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Check out more Industry Data Books, published by Grand View Research About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com/sector-reports-list Follow Us: LinkedIn | Twitter |
Archives
December 2023
Categories |